Viridian Therapeutics Inc. Watch

from 10-Q 77 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Disclosed. First Amendment to Loan and Security Agreement

from 8-K 68 pages Loan and Security Agreement

from 10-Q 6 pages Deferral Agreement Effective Date: April 6 , 20 20 Loan Agreement Date (Use Restated Date if Applicable): November 14 , 20 17 Borrower: Miragen Therapeutics, Inc. ☐ if This Box Is Checked, Additional Borrowers (“Additional Borrowers”) Are Listed in the Annex Attached Hereto (Borrower and Such Additional Borrowers, Collectively, “Borrower”). Loan Agreement: That Certain Loan and Security Agreement, Dated as of the Loan Agreement Date, Between Borrower, Additional Borrowers, if Any, and Silicon Valley Bank (“Bank”), as Amended, Restated or Otherwise Modified and in Effect From Time to Time. Guarantor(s) or Pledgor(s): ☐ if This Box Is Checked, the Obligations of Borrower Are Guaranteed or Secured by a Pledge of Assets and the Consent and Ratification Attached Hereto Shall Apply and Must Be Completed for Each Guarantor and/or Pledgor

from 8-K 35 pages Amended and Restated Loan and Security Agreement

from S-4/A 4 pages First Loan Modification Agreement

from S-4 34 pages Loan and Security Agreement